Fig 1.
Proposed treatment algorithm for 5-FU (Fluorouracil) coronary vasospasm patients.
Suggested treatment algorithm followed by cardio-oncology specialists at our institution.
Fig 2.
Summary of treatment assignments for 5-FU (Fluorouracil) associated coronary vasospasm patients.
Summary of treatment assignments for all patients who developed 5-FU (Fluorouracil) associated coronary vasospasm.
Table 1.
Baseline characteristics of all patients with vasospasm, and comparison of those of who continued 5-FU therapy with cardiac pre-treatment vs. those who stopped 5-FU therapy.
Fig 3.
Kaplan-Meier curves for overall survival and progression free survival for 5-FU associated coronary vasospasm patients.
Comparison of (A) overall survival and (B) progression free survival in patients who developed 5-FU associated coronary vasospasm and continued 5-FU therapy after receiving cardioprotective pre-treatment compared to those who stopped 5-FU therapy.